glp-1 next generation Beyond GLP-1: Review of Next-Generation Obesity Therapeutics GLP-1-based therapies for diabetes, obesity

Based upon self-reported data from approximately 12,000 customers subscribed to a comprehensive Hims & Hers weight loss offering, customers report having lost, on average, 10.2 pounds while on compounded GLP-1 injections and 6.3 pounds while on non-GLP-1 compounded oral medication kits, along with a reduced calorie diet and exercise, between their initial weight at consultation and their first check-in approximately 4 weeks later

Recent data suggests the risk may be greater than previously understood, particularly for people taking Wegovy, the higher-dose version of semaglutide used for weight loss

We dont know whether these other salts or these alternative salts of the same ingredient have the same benefit, Harrison said

GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Interestingly, this occurs despite a reduction in glucose uptake in muscle (Knauf et al., 2005), which is consistent with the increased muscle glucose uptake exhibited by mice lacking GLP-1R expression (Ayala et al., 2009)